Our Strategic and Commercial evaluation of pipeline programs is based on a combination of a cross-functional work stream rolled out in parallel with program specific therapeutic and market analysis.
These tailor-made analyses combined with available in-house data address:
Guidance on the implementation of the SOP and the development phase (1-2-3) dependent deliverables of the commercialization process is based on:
A systematic strategic analysis of a disease landscape provides the foundation for defining the commercial opportunity.
This interactive work stream with a multi-disciplinary product team enables cross-functional alignment in evaluating the value of the program.
Development of cross-functional recommendations for improving the differentiation strategy and increasing the value proposition.